Management of Persistent Bacteremia Caused by Methicillin-Resistant Staphylococcus aureus: A Survey of Infectious Diseases Consultants
We conducted a survey in 2005 of infectious diseases consultants and asked about persistent bacteremia due to methicillin-resistant Staphylococcus aureus. Many consultants perceived an increase in the frequency of illness, and, when presented with vancomycin minimum inhibitory concentrations approac...
Gespeichert in:
| Veröffentlicht in: | Clinical infectious diseases 2006-09, Vol.43 (5), p.e42-e45 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | e45 |
|---|---|
| container_issue | 5 |
| container_start_page | e42 |
| container_title | Clinical infectious diseases |
| container_volume | 43 |
| creator | Hageman, Jeffrey C. Liedtke, Laura A. Sunenshine, Rebecca H. Strausbaugh, Larry J. McDonald, L. Clifford Tenover, Fred C. |
| description | We conducted a survey in 2005 of infectious diseases consultants and asked about persistent bacteremia due to methicillin-resistant Staphylococcus aureus. Many consultants perceived an increase in the frequency of illness, and, when presented with vancomycin minimum inhibitory concentrations approaching the limit of the susceptible range, most consultants indicated that they would switch to newer antimicrobial agents for treatment. |
| doi_str_mv | 10.1086/506568 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68712008</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1152551931</sourcerecordid><originalsourceid>FETCH-LOGICAL-c342t-a63bf411a4f6ccf457bc586829ab5c13394d9f91d1135465682eeaa7381832783</originalsourceid><addsrcrecordid>eNpdkdtu1DAQhiNERQ_AIyCLC-5CPfEhDndlKbTqVlRdkBA31sQ7oS45LHaM2BfguZtoV1TiamY0nz6N5s-yl8DfAjf6VHGttHmSHYESZa5VBU-nniuTSyPMYXYc4z3nAIarZ9khaGM0SDjK_l5jjz-oo35kQ8NuKEQfx3l6j26kQJ1HtsAUac3qLbum8c4737a-z29pRnFCVyNu7rbt4AbnUmSYAqX4jp2xVQq_aTuLL_uG3OiHaf3BR8JIkS2GPqZ2NsTn2UGDbaQX-3qSff14_mVxkS8_f7pcnC1zJ2Qx5qhF3UgAlI12rpGqrJ0y2hQV1sqBEJVcV00FawCh5PyRggixFAaMKEojTrI3O-8mDL8SxdF2PjpqW-xpus1qU0LB-Qy-_g-8H1Lop9tsAVWlAKB6tLkwxBiosZvgOwxbC9zOsdhdLBP4am9LdUfrR2yfwwTkO2B-_p9_eww_rS5FqezFt-92tby9kjflyhrxAKJ-lyM</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>219951119</pqid></control><display><type>article</type><title>Management of Persistent Bacteremia Caused by Methicillin-Resistant Staphylococcus aureus: A Survey of Infectious Diseases Consultants</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>JSTOR Archive Collection A-Z Listing</source><source>Oxford University Press Journals All Titles (1996-Current)</source><creator>Hageman, Jeffrey C. ; Liedtke, Laura A. ; Sunenshine, Rebecca H. ; Strausbaugh, Larry J. ; McDonald, L. Clifford ; Tenover, Fred C.</creator><creatorcontrib>Hageman, Jeffrey C. ; Liedtke, Laura A. ; Sunenshine, Rebecca H. ; Strausbaugh, Larry J. ; McDonald, L. Clifford ; Tenover, Fred C. ; Infectious Diseases Society of America Emerging Infections Network ; Infectious Diseases Society of America Emerging Infections Network</creatorcontrib><description>We conducted a survey in 2005 of infectious diseases consultants and asked about persistent bacteremia due to methicillin-resistant Staphylococcus aureus. Many consultants perceived an increase in the frequency of illness, and, when presented with vancomycin minimum inhibitory concentrations approaching the limit of the susceptible range, most consultants indicated that they would switch to newer antimicrobial agents for treatment.</description><identifier>ISSN: 1058-4838</identifier><identifier>EISSN: 1537-6591</identifier><identifier>DOI: 10.1086/506568</identifier><identifier>PMID: 16886141</identifier><language>eng</language><publisher>United States: The University of Chicago Press</publisher><subject>Anti-Bacterial Agents - therapeutic use ; Bacteremia - drug therapy ; Bacteria ; Blood diseases ; Data Collection ; Disease management ; Drug resistance ; Humans ; Infection Control Practitioners ; Methicillin Resistance ; Staphylococcal Infections - drug therapy ; Staphylococcus aureus - drug effects ; Staphylococcus aureus - isolation & purification</subject><ispartof>Clinical infectious diseases, 2006-09, Vol.43 (5), p.e42-e45</ispartof><rights>Copyright University of Chicago, acting through its Press Sep 1, 2006</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c342t-a63bf411a4f6ccf457bc586829ab5c13394d9f91d1135465682eeaa7381832783</citedby><cites>FETCH-LOGICAL-c342t-a63bf411a4f6ccf457bc586829ab5c13394d9f91d1135465682eeaa7381832783</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16886141$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hageman, Jeffrey C.</creatorcontrib><creatorcontrib>Liedtke, Laura A.</creatorcontrib><creatorcontrib>Sunenshine, Rebecca H.</creatorcontrib><creatorcontrib>Strausbaugh, Larry J.</creatorcontrib><creatorcontrib>McDonald, L. Clifford</creatorcontrib><creatorcontrib>Tenover, Fred C.</creatorcontrib><creatorcontrib>Infectious Diseases Society of America Emerging Infections Network</creatorcontrib><creatorcontrib>Infectious Diseases Society of America Emerging Infections Network</creatorcontrib><title>Management of Persistent Bacteremia Caused by Methicillin-Resistant Staphylococcus aureus: A Survey of Infectious Diseases Consultants</title><title>Clinical infectious diseases</title><addtitle>Clinical Infectious Diseases</addtitle><description>We conducted a survey in 2005 of infectious diseases consultants and asked about persistent bacteremia due to methicillin-resistant Staphylococcus aureus. Many consultants perceived an increase in the frequency of illness, and, when presented with vancomycin minimum inhibitory concentrations approaching the limit of the susceptible range, most consultants indicated that they would switch to newer antimicrobial agents for treatment.</description><subject>Anti-Bacterial Agents - therapeutic use</subject><subject>Bacteremia - drug therapy</subject><subject>Bacteria</subject><subject>Blood diseases</subject><subject>Data Collection</subject><subject>Disease management</subject><subject>Drug resistance</subject><subject>Humans</subject><subject>Infection Control Practitioners</subject><subject>Methicillin Resistance</subject><subject>Staphylococcal Infections - drug therapy</subject><subject>Staphylococcus aureus - drug effects</subject><subject>Staphylococcus aureus - isolation & purification</subject><issn>1058-4838</issn><issn>1537-6591</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdkdtu1DAQhiNERQ_AIyCLC-5CPfEhDndlKbTqVlRdkBA31sQ7oS45LHaM2BfguZtoV1TiamY0nz6N5s-yl8DfAjf6VHGttHmSHYESZa5VBU-nniuTSyPMYXYc4z3nAIarZ9khaGM0SDjK_l5jjz-oo35kQ8NuKEQfx3l6j26kQJ1HtsAUac3qLbum8c4737a-z29pRnFCVyNu7rbt4AbnUmSYAqX4jp2xVQq_aTuLL_uG3OiHaf3BR8JIkS2GPqZ2NsTn2UGDbaQX-3qSff14_mVxkS8_f7pcnC1zJ2Qx5qhF3UgAlI12rpGqrJ0y2hQV1sqBEJVcV00FawCh5PyRggixFAaMKEojTrI3O-8mDL8SxdF2PjpqW-xpus1qU0LB-Qy-_g-8H1Lop9tsAVWlAKB6tLkwxBiosZvgOwxbC9zOsdhdLBP4am9LdUfrR2yfwwTkO2B-_p9_eww_rS5FqezFt-92tby9kjflyhrxAKJ-lyM</recordid><startdate>20060901</startdate><enddate>20060901</enddate><creator>Hageman, Jeffrey C.</creator><creator>Liedtke, Laura A.</creator><creator>Sunenshine, Rebecca H.</creator><creator>Strausbaugh, Larry J.</creator><creator>McDonald, L. Clifford</creator><creator>Tenover, Fred C.</creator><general>The University of Chicago Press</general><general>Oxford University Press</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7T2</scope><scope>7T7</scope><scope>7U7</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>20060901</creationdate><title>Management of Persistent Bacteremia Caused by Methicillin-Resistant Staphylococcus aureus: A Survey of Infectious Diseases Consultants</title><author>Hageman, Jeffrey C. ; Liedtke, Laura A. ; Sunenshine, Rebecca H. ; Strausbaugh, Larry J. ; McDonald, L. Clifford ; Tenover, Fred C.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c342t-a63bf411a4f6ccf457bc586829ab5c13394d9f91d1135465682eeaa7381832783</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Anti-Bacterial Agents - therapeutic use</topic><topic>Bacteremia - drug therapy</topic><topic>Bacteria</topic><topic>Blood diseases</topic><topic>Data Collection</topic><topic>Disease management</topic><topic>Drug resistance</topic><topic>Humans</topic><topic>Infection Control Practitioners</topic><topic>Methicillin Resistance</topic><topic>Staphylococcal Infections - drug therapy</topic><topic>Staphylococcus aureus - drug effects</topic><topic>Staphylococcus aureus - isolation & purification</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hageman, Jeffrey C.</creatorcontrib><creatorcontrib>Liedtke, Laura A.</creatorcontrib><creatorcontrib>Sunenshine, Rebecca H.</creatorcontrib><creatorcontrib>Strausbaugh, Larry J.</creatorcontrib><creatorcontrib>McDonald, L. Clifford</creatorcontrib><creatorcontrib>Tenover, Fred C.</creatorcontrib><creatorcontrib>Infectious Diseases Society of America Emerging Infections Network</creatorcontrib><creatorcontrib>Infectious Diseases Society of America Emerging Infections Network</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hageman, Jeffrey C.</au><au>Liedtke, Laura A.</au><au>Sunenshine, Rebecca H.</au><au>Strausbaugh, Larry J.</au><au>McDonald, L. Clifford</au><au>Tenover, Fred C.</au><aucorp>Infectious Diseases Society of America Emerging Infections Network</aucorp><aucorp>Infectious Diseases Society of America Emerging Infections Network</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Management of Persistent Bacteremia Caused by Methicillin-Resistant Staphylococcus aureus: A Survey of Infectious Diseases Consultants</atitle><jtitle>Clinical infectious diseases</jtitle><addtitle>Clinical Infectious Diseases</addtitle><date>2006-09-01</date><risdate>2006</risdate><volume>43</volume><issue>5</issue><spage>e42</spage><epage>e45</epage><pages>e42-e45</pages><issn>1058-4838</issn><eissn>1537-6591</eissn><abstract>We conducted a survey in 2005 of infectious diseases consultants and asked about persistent bacteremia due to methicillin-resistant Staphylococcus aureus. Many consultants perceived an increase in the frequency of illness, and, when presented with vancomycin minimum inhibitory concentrations approaching the limit of the susceptible range, most consultants indicated that they would switch to newer antimicrobial agents for treatment.</abstract><cop>United States</cop><pub>The University of Chicago Press</pub><pmid>16886141</pmid><doi>10.1086/506568</doi></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1058-4838 |
| ispartof | Clinical infectious diseases, 2006-09, Vol.43 (5), p.e42-e45 |
| issn | 1058-4838 1537-6591 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_68712008 |
| source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; JSTOR Archive Collection A-Z Listing; Oxford University Press Journals All Titles (1996-Current) |
| subjects | Anti-Bacterial Agents - therapeutic use Bacteremia - drug therapy Bacteria Blood diseases Data Collection Disease management Drug resistance Humans Infection Control Practitioners Methicillin Resistance Staphylococcal Infections - drug therapy Staphylococcus aureus - drug effects Staphylococcus aureus - isolation & purification |
| title | Management of Persistent Bacteremia Caused by Methicillin-Resistant Staphylococcus aureus: A Survey of Infectious Diseases Consultants |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T21%3A34%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Management%20of%20Persistent%20Bacteremia%20Caused%20by%20Methicillin-Resistant%20Staphylococcus%20aureus:%20A%20Survey%20of%20Infectious%20Diseases%20Consultants&rft.jtitle=Clinical%20infectious%20diseases&rft.au=Hageman,%20Jeffrey%20C.&rft.aucorp=Infectious%20Diseases%20Society%20of%20America%20Emerging%20Infections%20Network&rft.date=2006-09-01&rft.volume=43&rft.issue=5&rft.spage=e42&rft.epage=e45&rft.pages=e42-e45&rft.issn=1058-4838&rft.eissn=1537-6591&rft_id=info:doi/10.1086/506568&rft_dat=%3Cproquest_cross%3E1152551931%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=219951119&rft_id=info:pmid/16886141&rfr_iscdi=true |